Reproductive Health Travel Fund Act of 2026

Right to Contraception Act (S. 422/H.R. 999) A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. (S.J. Res. 732) Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. (H.J. Res. 1285) SAFE Training for OBGYNs Act (H.R. 9441) Let Doctors Provide Reproductive Health Care Act (S. 4879/H.R. 9445) Reproductive Health Travel Fund Act of 2026 (S. 4922)

Client expense: $79,708 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- urged House and Senate offices to cosponsor the bill -H.Res.1389 Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care- met with staff and drafted text -Reproductive Health Travel Fund Act (not yet introduced)- worked on drafting text -S.Res.732 / H.Res.1285 Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. Reviewed and endorsed legislation -S.4701 Freedom to Travel for Health Care Act of 2026- Reviewed and endorsed legislation - Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - S.4701 Freedom to Travel for Health Care Act of 2026- Made social media in support of bill, social media content development -S. 4922- Reproductive Health Travel Fund Act of 2026- social media content development - H.R. 9441- SAFE Training for OBGYNs Act- Endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff to discuss bill reintroduction

Client expense: $9,749 · Firm income: Not reported

Advocacy in favor of appropriations for sexual and reproductive health (House and Senate) (no bill # available) Advocacy in favor of the Reproductive Health Care Accessibility Act of 2026 (HR 8829/ S.4540) (House and Senate) Advocacy for expanding abortion rights (House) Advocacy for abortion rights and access proposal (no bill # available) (Senate & House) Advocacy for expansive abortion access through draft legislation recognizing the broad right to abortion including access for immigrants and people with low incomes (no bill # available) (House & Senate) Advocacy for robust abortion rights bill (no bill # available) (House and Senate) Advocacy for universal child care proposal (no bill # available) (Senate & House) Advocacy for elimination of the Weldon Amendment from the appropriations package (no bill # available) (House and Senate) Advocacy for EACH Act (H.R. 4611, S. 2377) (House and Senate) Advocacy against FACE Act Repeal Act (H.R. 589) (House) Advocacy for Right to IVF Act (no bill # available) (Senate) Advocacy for a resolution in support of mifepristone (S. 732) (Senate) Advocacy for Reproductive Health Travel Fund Act (S. 4922) (Senate) Advocacy for Federal Workforce Reproductive Rights Protection Act (H.R. 9448) (House) Advocacy for SAFE training for OBGYNs Act (H.R. 9441) (House) Advocacy for Freedom to Travel for Health Care Act (S. 4701) (Senate) Advocacy for Let Doctors Provide Reproductive Health Care Act (S. 4879) (Senate) Advocacy for veterans' abortion access (H.J. Res. 144/S.J. Res. 103) (House & Senate) Advocacy for MARCH Act (H.R.3969/S.4574) (House & Senate) Advocacy for fertility care and coverage for military service members (no bill # available) (House & Senate) Advocacy against anti-abortion riders in FY27 appropriations bills including the Hyde and Weldon Amendments, and riders in the Defense and Military Construction and Veterans Affairs appropriations packages (no bill # available) (House & Senate) Advocacy for veterans' contraception access (Equal Access to Contraception for Veterans Act - H.R.211) (House & Senate) Advocacy for resolution recognizing the safety of medication abortion (S.Res.732) (Senate) Advocacy for Right to Contraception Act discharge petition (H.R. 999 and H.R. 830) (House)

Stop Anti-Abortion Disinformation (SAD) Act (S. 589/H.R. 846) Abortion Care Awareness Act (H.R. 2497) OPPOSE: Born-Alive Abortion Survivors Protection Act (H.R. 21/S. 6) OPPOSE: Repeal of the FACE Act (H.R. 589) EACH Act (H.R. 4611/S. 2377) OPPOSE: Supporting Pregnant and Parenting Women and Families Act (H.R. 6945) OPPOSE: Nonprofit status of abortion funds (H.R. 7286) Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Veterans Affairs relating to "Reproductive Health Services" (H.J. Res 144 /S.J. 103 ) Abortion Provider Appreciation Day Resolution (S Con Res. 28/H Con Res. 78) Reproductive Health Care Training Act (H.R. 9420/S. 4878) Let Doctors Provide Reproductive Health Act (S. 4879) The Freedom to Travel for Health Care Act (S. 4701) Reproductive Health Travel Fund Act (H.R. 4625/S. 4922) Resolution Regarding the Safety of Mifepristone (S. Res. 732/H. Res. 1285)

Client expense: $21,703 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.